Advertisement
Advertisement
HIMS
Hims & Hers Health, Inc.
26.00
USDSponsored
+1.94
+8.06%
Nov 06, 15:59 UTC -5
Closed
After-Market
26.05
+0.05
+0.19%
Hims & Hers Health, Inc. (HIMS) Earnings
HIMS Earnings Reports
Positive Surprise Ratio
HIMS beat 15 of 23 last estimates.
65%
Next Report
Tomorrow AMC
Date of Next Report
Nov 09, 2026
Estimate for Q3 26 (Revenue/ EPS)
$910.75M
/$0.06
Implied change from Q2 26 (Revenue/ EPS)
+20.91%
/-116.22%
Implied change from Q3 25 (Revenue/ EPS)
+52.05%
/--
Hims & Hers Health, Inc. earnings per share and revenue
On Aug 10, 2026, HIMS reported earnings of -0.37 USD per share (EPS) for Q2 26, missing the estimate of -0.01 USD, resulting in a -2487.41% surprise. Revenue reached 753.21 million, compared to an expected 713.89 million, with a 5.51% difference. The market reacted with a -3.97% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 10 analysts forecast an EPS of 0.06 USD, with revenue projected to reach 910.75 million USD, implying an decrease of -116.22% EPS, and increase of 20.91% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
10x Genomics, Inc. Class A Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.26
Actual
-$0.15
Surprise
+43.35%
Doximity, Inc.
Report Date
Nov 05, 2026 For Q2 27
Estimate
$0.35
Actual
$0.36
Surprise
+0.56%
iRhythm Holdings, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.06
Actual
$0.82
Surprise
+1,214.10%
Privia Health Group, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.09
Actual
$0.10
Surprise
+3.73%
Schrodinger, Inc. Common Stock
Report Date
Nov 04, 2026 For Q3 26
Estimate
-$0.70
Actual
-$0.50
Surprise
+29.57%
Enovis Corporation
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.78
Actual
$0.88
Surprise
+12.07%
Evolent Health, Inc Class A Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.05
Actual
$0.06
Surprise
+13.21%
Fulgent Genetics, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.66
Actual
-$0.09
Surprise
+86.43%
Health Catalyst, Inc Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.04
Actual
-$0.03
Surprise
+38.14%
CareCloud, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.11
Actual
$0.14
Surprise
+19.35%
FAQ
What were Hims & Hers Health, Inc.'s earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Hims & Hers Health, Inc. reported EPS of -$0.37, missing estimates by -2487.41%, and revenue of $753.21M, 5.51% above expectations.
How did the market react to Hims & Hers Health, Inc.'s Q2 2026 earnings?
The stock price moved down -3.97%, changed from $31.77 before the earnings release to $30.51 the day after.
When is Hims & Hers Health, Inc. expected to report next?
The next earning report is scheduled for Nov 09, 2026.
What are the forecasts for Hims & Hers Health, Inc.'s next earnings report?
Based on 10
analysts, Hims & Hers Health, Inc. is expected to report EPS of $0.06 and revenue of $910.75M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.